Walking Fish launches to pioneer B cell therapies

Walking Fish emerged from stealth to join the ranks of new companies taking on cell therapy development, but it’s setting out to create an entirely new therapeutic modality in B cell therapies. 

Nearly every major class of immune cells, including T cells, NK cells and macrophages, is being deployed as a therapeutic modality, but B cells have remained relatively unexplored in the clinic, in part because they’re challenging to engineer. ...